Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection

NCT03107377 is registered in ClinicalTrials.gov with Evofem Inc. as lead sponsor.

NCT NCT03107377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03107377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Lead sponsor
Evofem Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
November 3, 2017
Completion date
August 22, 2019
Enrollment
860 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection